Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Similar articles for PubMed (Select 10522847)

1.

Radiofrequency ablation of breast cancer: first report of an emerging technology.

Jeffrey SS, Birdwell RL, Ikeda DM, Daniel BL, Nowels KW, Dirbas FM, Griffey SM.

Arch Surg. 1999 Oct;134(10):1064-8.

PMID:
10522847
2.

Radiofrequency ablation of small breast cancer followed by surgical resection.

Noguchi M, Earashi M, Fujii H, Yokoyama K, Harada K, Tsuneyama K.

J Surg Oncol. 2006 Feb 1;93(2):120-8.

PMID:
16425291
3.
4.

A phase II trial of image-guided radiofrequency ablation of small invasive breast carcinomas: use of saline-cooled tip electrode.

Khatri VP, McGahan JP, Ramsamooj R, Griffey S, Brock J, Cronan M, Wilkendorf S.

Ann Surg Oncol. 2007 May;14(5):1644-52. Epub 2007 Feb 15.

PMID:
17508251
5.

Radiofrequency ablation of invasive breast carcinomas: a phase II trial.

Medina-Franco H, Soto-Germes S, Ulloa-Gómez JL, Romero-Trejo C, Uribe N, Ramirez-Alvarado CA, Robles-Vidal C.

Ann Surg Oncol. 2008 Jun;15(6):1689-95. doi: 10.1245/s10434-008-9875-4. Epub 2008 Mar 25.

PMID:
18363072
6.

Radiofrequency thermal ablation of breast cancer local recurrence: a phase II clinical trial.

Garbay JR, Mathieu MC, Lamuraglia M, Lassau N, Balleyguier C, Rouzier R.

Ann Surg Oncol. 2008 Nov;15(11):3222-6. doi: 10.1245/s10434-008-0026-8. Epub 2008 Aug 15.

PMID:
18709415
7.

Histopathological and immunohistochemical evaluations of breast cancer treated with radiofrequency ablation.

Motoyoshi A, Noguchi M, Earashi M, Zen Y, Fujii H.

J Surg Oncol. 2010 Oct 1;102(5):385-91. doi: 10.1002/jso.21429.

PMID:
19877159
8.

Use of cytokeratin 8 immunohistochemistry for assessing cell death after radiofrequency ablation of breast cancers.

Kreb DL, Bosscha K, Ernst MF, Rutten MJ, Jager GJ, van Diest PJ, van der Linden JC.

Biotech Histochem. 2011 Dec;86(6):404-12. doi: 10.3109/10520295.2010.517473. Epub 2010 Oct 18.

PMID:
20950219
9.

Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study.

Fornage BD, Sneige N, Ross MI, Mirza AN, Kuerer HM, Edeiken BS, Ames FC, Newman LA, Babiera GV, Singletary SE.

Radiology. 2004 Apr;231(1):215-24. Epub 2004 Feb 27.

PMID:
14990810
10.

Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients.

Izzo F, Thomas R, Delrio P, Rinaldo M, Vallone P, DeChiara A, Botti G, D'Aiuto G, Cortino P, Curley SA.

Cancer. 2001 Oct 15;92(8):2036-44.

PMID:
11596017
11.

Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods.

Morimoto M, Sugimori K, Shirato K, Kokawa A, Tomita N, Saito T, Tanaka N, Nozawa A, Hara M, Sekihara H, Shimada H, Imada T, Tanaka K.

Hepatology. 2002 Jun;35(6):1467-75.

PMID:
12029632
12.

Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision.

Burak WE Jr, Agnese DM, Povoski SP, Yanssens TL, Bloom KJ, Wakely PE, Spigos DG.

Cancer. 2003 Oct 1;98(7):1369-76.

13.

[Radiofrequency ablation of breast carcinomas: preliminary results of a clinical trial].

Apesteguía L, Ovelar A, Domínguez-Cunchillos F, Alfaro C, Trujillo R, Sanz MA, de Miguel C, Reparaz B, Ruiz de Azúa Y.

Radiologia. 2009 Nov-Dec;51(6):591-600. doi: 10.1016/j.rx.2009.07.003. Epub 2009 Nov 12. Spanish.

14.

Feasibility study on radiofrequency ablation followed by partial mastectomy for stage I breast cancer patients.

Imoto S, Wada N, Sakemura N, Hasebe T, Murata Y.

Breast. 2009 Apr;18(2):130-4. doi: 10.1016/j.breast.2009.02.008. Epub 2009 Mar 26.

PMID:
19324550
15.

Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".

Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS.

Cancer. 2003 Jun 15;97(12):3027-35.

16.

Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation.

Hayashi AH, Silver SF, van der Westhuizen NG, Donald JC, Parker C, Fraser S, Ross AC, Olivotto IA.

Am J Surg. 2003 May;185(5):429-35.

PMID:
12727562
18.

[Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].

Pitton MB, Herber S, Raab P, Mönch C, Wunsch M, Schneider J, Schweden F, Otto G, Thelen M.

Rofo. 2003 Nov;175(11):1525-31. German.

PMID:
14610704
19.

Image and pathological changes after radiofrequency ablation of invasive breast cancer: a pilot study of nonsurgical therapy of early breast cancer.

Yoshinaga Y, Enomoto Y, Fujimitsu R, Shimakura M, Nabeshima K, Iwasaki A.

World J Surg. 2013 Feb;37(2):356-63. doi: 10.1007/s00268-012-1820-9.

PMID:
23052813
20.

Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies.

Clasen S, Krober SM, Kosan B, Aebert H, Fend F, Bomches A, Claussen CD, Pereira PL.

Cancer. 2008 Dec 1;113(11):3121-9. doi: 10.1002/cncr.23882.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk